Hemoglobin variants
Genetic mutations produce over 1,000 hemoglobin variants.
Hemoglobin variants are structural alterations in the hemoglobin protein, caused by mutations in the genes coding for the globin chains that make up the molecule. These variants can affect the structure, properties, or stability of hemoglobin, and their physiological effects range from minor to severe, including diseases such as sickle-cell anemia and thalassemia.
- Field
- Molecular biology, genetics, hematology
- Known for
- Over 1,000 known mutations in hemoglobin genes; variants can cause disease or be non-pathological
- Types
- Normal hemoglobins (HbA, HbA2, HbF) and pathologic variants (e.g., HbS, HbC, HbE)
Lore & Background
Hemoglobin is a protein that transports oxygen in the blood. Genetic differences lead to structural variants in the hemoglobin protein structure. Some variants can cause disease while others have little to no effect. The normal hemoglobin types are Hemoglobin A (HbA), which makes up 95–98% of total hemoglobin in adults, Hemoglobin A2 (HbA2), which constitutes 2–3% of total hemoglobin in adults, and Hemoglobin F (HbF), which is the predominant hemoglobin in the fetus during pregnancy, and may persist in small amounts in adults.
Hemoglobin variants occur when there are mutations in specific genes that code for the protein chains, known as globins, which make up the hemoglobin molecule. This leads to amino acid substitutions in the hemoglobin molecule that could affect the structure, properties, and/or the stability of the hemoglobin molecule. There are over 1,000 known mutations in the genes coding for hemoglobin in humans.
The physiological effects of these variants can range from minor to severe. Mutations can cause impaired production of hemoglobin (thalassemia) or produce structurally altered hemoglobins. Some hemoglobin variants, such as HbS which causes sickle-cell anemia, are responsible for severe diseases and are considered hemoglobinopathies. Other variants cause no detectable pathology, and are thus considered non-pathological variants.
Reader's Guide
Hemoglobin variants are significant because they represent a large class of genetic disorders and benign polymorphisms affecting a fundamental oxygen-transport protein. Over 1,000 known mutations in globin genes can lead to thalassemia or structural hemoglobin variants. Pathologic variants like HbS (sickle-cell anemia) and HbC cause severe disease, while many others are non-pathological. The study of these variants has advanced understanding of protein structure-function relationships, genetic inheritance, and population genetics. Detection methods include isoelectric focusing and high-performance liquid chromatography, and in some countries all newborns are tested for hemoglobinopathies, thalassemias, and HbS. A research database of hemoglobin variants is maintained by Penn State University. The legacy of hemoglobin variant research includes improved diagnosis, carrier screening, and management of hemoglobin disorders worldwide.
Did You Know?
- Normal adult hemoglobin includes HbA (95–98%), HbA2 (2–3%), and small amounts of HbF.
- HbS is a hemoglobin variant that causes sickle-cell anemia, a severe hemoglobinopathy.
- Hemoglobin variants can be discovered through routine laboratory testing or evaluation of patients with severe anemia.
Frequently Asked Questions
What are Hemoglobin variants?
Hemoglobin variants are structural changes in the hemoglobin protein that arise from mutations in the genes encoding its globin chains. These alterations can shift the molecule's shape, stability, or functional properties, producing effects that range from completely benign to life-threatening.
How many Hemoglobin variants are known?
Researchers have catalogued well over 1,000 distinct mutations in the hemoglobin genes, making it one of the most extensively mapped sets of protein variants in human genetics. Not every one of these carries a clinical consequence.
What types of Hemoglobin variants exist?
They split into normal physiological forms—HbA, HbA2, and HbF—and pathologic variants such as HbS, HbC, and HbE. The normal forms serve essential roles across a person's lifespan, while the pathologic ones disrupt oxygen transport or red-cell integrity.
Can a Hemoglobin variant be harmless?
Yes. Many of the 1,000-plus catalogued mutations produce no detectable change in red-cell behavior or oxygen-carrying capacity, meaning the carrier lives entirely normally. Only a subset cross the threshold into causing anemia, hemolysis, or other clinical disease.
Why are Hemoglobin variants important in genetics and hematology?
They sit at the intersection of molecular biology, genetics, and hematology because a single amino-acid swap can cascade into severe conditions like sickle-cell anemia or thalassemia. Studying them gives researchers a direct window into how tiny coding changes reshape a protein's behavior and, ultimately, a patient's physiology.
More in Genetic disorders with no OMIM 1-24
Spotted an error? Know more?
Reader corrections go straight into our review queue. Suggest an edit · How this site is sourced